•
Sep 30, 2019

ResMed Q1 2020 Earnings Report

Total Revenue
$681M
Previous year: $588M
+15.8%
EPS
$0.93
Previous year: $0.81
+14.8%
Non-GAAP Gross Margin
59.6%
Gross Profit
$405M
Previous year: $343M
+18.1%
Cash and Equivalents
$172M
Previous year: $230M
-25.2%
Free Cash Flow
$140M
Previous year: $35.1M
+297.7%
Total Assets
$4.15B
Previous year: $3.07B
+35.4%

ResMed

ResMed

ResMed Revenue by Segment